Press releases

• Life isn't 2D, so why should our encyclopaedias be? - Proteopedia
  
  
• Cancer signatures uncovered
  
  
• Human brains pay a price for being big
  
  
• Guidelines to prevent genetic discrimination
  
  
• Gene-expression profiling of the effects of liver toxins
  
  
• Large-scale community protein annotation - WikiProteins
  
  
• Mapping of prostate cancer genes opens the door to new treatments
  
  
• Break it down: genome sequence of Podospora anserina reveals unsuspected ability to use complex carbon sources
  
  
• Supplements are not nutritious
  
  
• On the trail of rogue genetically modified pathogens
  
  
• Scientists unravel the genetic coding of the pea
  
  
• New gene prediction method capitalizes on multiple genomes
  
  
• Generating antibodies in high throughput
  
  
• Blind mice shed light on human sight loss
  
  
• Bar flies: fruit flies help unravel the genetics of alcohol sensitivity
  
  
• Decoding effects of toxins on embryo development
  
  
• Free shopping in a virtual bazaar of gene regulation data
  
  
• Umbilical cord gene expression signals premature babies' lung disease risk
  
  
• The molecular signature of loneliness
  
  
• Air pollution link to clogged arteries
  
  
• The sound of proteins
  
  
• 'Drunk' fruit flies could shed light on genetic basis of human alcohol abuse
  
  
• Predicting chemotherapy outcome
  
  
• New species from old data
  
  
• Fruit flies unlock Methuselah's secrets
  
  
• Comparisons of the new mouse genome sequence
  
  
• Making sense of the human genome: researchers characterize a crucial family of signaling proteins in the human genome
  
  
• Stanford researchers argue that there is indeed a biological base for race
  
  
• Genomic study breathes new life into asthma research
  
  
• Why does a worm need nearly as many genes as a man?
  
  
• Genomes on 'chips' boon to cancer research
  
  
• BioMed Central is pleased to announce the publication of Sydney Brenner's autobiography
  
  
• A genomic blueprint for a sense of smell
  
  
• Researchers to publish a third historic human genome article in Genome Biology this week
  
  
• Human Genome project leaves much of human variation unsampled
  
  
• Diagnosis on a chip - molecular profiling that could improve diagnosis and help design better drugs
  
  
• Gene "shaving" could help doctors predict the efficacy of cancer treatments
  
  
• Whither genomics?
  
  
• Current Science Group declares support for 'PubMed Central' historic development
  
  
• Science publishing - beginning of a revolution?
  
  

Mapping of prostate cancer genes opens the door to new treatments

Genetic changes during the initiation and progression of prostate cancer have eluded scientists to date. Now for the first time researchers have identified a specific gene expression profile of prostate cancer stem cells, with important implications for future treatments. The findings, published in the open access journal Genome Biology, revealed 581 genes that are differentially expressed in certain prostate cancer cells, highlighting several pathways important in the cancer stem-cells biology, and offering targets for new chemopreventative and chemotherapeutic approaches.

The cells in the study represent less than 0.1% of prostate cancer tumors, and have properties that mark them out as cancer stem cells. The cells renew themselves, are highly invasive, and have a longer lifetime than normal stem cells. They also feature a primitive epithelial phenotype and can differentiate to recapitulate phenotypes seen in prostate tumors. The cells are found in all stages and types of prostate cancer.

Expression profiling of prostate cancers typically uses tumor cell mass samples to identify individual genes. In this study, researchers harnessed advances in microarray and target labelling technologies to produce a functionally annotated expression profile of these prostate cancer stem cells.

The team, from the YCR Cancer Research Unit at the University of York and Pro-cure Therapeutics Ltd, created a malignant stem cell signature by combining genes significantly overexpressed in stem cells with those significantly overexpressed in malignant stem cells. Quantitative RT-PCR, flow cytometry and immunocytochemistry were used to validate the gene expression changes.

Genes associated with inflammation were prominent in the cancer stem cell expression profile. Potential therapeutic target NFκB is known to promote cell survival. The researchers showed that an NFκB inhibitor triggered programmed cell death in cancer stem cells, but spared normal stem cells. This provides a potential therapeutic target for this rare group of cells, which are unlikely to be affected by current chemotherapy regimens.

"For the first time we are looking at the subpopulation of cancer cells which actually initiate new tumors" explains Anne Collins, who coordinated the study. "The genetic profiling we have carried out should stimulate new lines of research directed towards stem cell treatments for cancer"

####

Article:

Gene expression profiling of human prostate cancer stem cells reveals a pro-inflammatory phenotype and the importance of extracellular matrix interactions

Richard Birnie, Steven D Bryce, Claire Roome, Vincent Dussupt, Alastair Droop, Shona H Lang, Paul A Berry, Catherine F Hyde, John L Lewis, Michael J Stower, Norman J Maitland and Anne T Collins

Genome Biology 2008, 9:R83.

http://genomebiology.com

Please quote the journal in any story you write, and link to the article if you are writing for the web.

For more information about this study, or about the journal, contact Chalotte Webber by email at press@biomedcentral.com or by phone on +44 (0) 20 7631 9980.

Please quote the journal in any story you write. If you are writing for the web, please link to the article. All articles are available free of charge, according to BioMed Central's Open Access policy.

####

Genome Biology publishes articles from the full spectrum of biology. Subjects covered include any aspect of molecular, cellular, organismal or population biology studied from a genomic perspective, as well as genomics, proteomics, bioinformatics, genomic methods (including structure prediction), computational biology, sequence analysis (including large-scale and cross-genome analyses), comparative biology and evolution. Genome Biology has an impact factor of 7.17.

BioMed Central, (http://www.biomedcentral.com) is an independent online publishing house committed to providing immediate access without charge to the peer-reviewed biological and medical research it publishes. This commitment is based on the view that open access to research is essential to the rapid and efficient communication of science.